Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE), American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA).

AI helps cardiologists track new drug's effect on inflammation
The combination of AI and CT helped Nehal Mehta, MD, and colleagues track the performance of a new drug designed to target coronary inflammation.
AI improves CT assessments, boosts care for real-world heart patients
Automated AI-generated measurements combined with annotated CT images can improve treatment planning and help referring physicians and patients better understand their disease, explained Sarah Jane Rinehart, MD, director of cardiac imaging with Charleston Area Medical Center.
First-in-human trial shows potential of guiding CABG with cardiac CT and AI—no ICA required
An independent heart team blinded to ICA results was able to deliver helpful guidance for CABG procedures for 99.1% of patients using just CCTA and FFR_CT alone. This approach is safe and feasible, researchers wrote, and the next step is to gather additional data.
Cardiology, radiology groups urge insurance provider to rethink imaging policy
SCAI and four other major healthcare organizations signed a joint letter in support of intravascular ultrasound.
SPECT still has an important role to play in nuclear cardiology
"I see, at least for the next decade, this being a SPECT and PET world, not one or the other," explained Tim Bateman, MD.

$To prevent the risk of patients developing heart failure from chemotherapy agents in cancer care, patients are typically have their left ventricular ejection fraction (LVEF) or myocardial strain monitored using either echocardiography or equilibrium radionuclide angiography/multigated acquisition (ERNA/MUGA). If cardiac damager occurs, the treatment is discontinue or pause treatment. Cardiac imaging to assess chemotherapy-induced cardiotoxicity using strain echo.$

Succeeding with Cancer: Using Imaging to Avoid Treatment-induced Heart Failure

Treating today’s cancer patient no longer means simply targeting the cancer. Given the known cardiotoxicities of some established chemotherapies and the possibility that newer approaches may damage the heart, oncologists, cardiologists and imaging specialists now work together to detect and minimize the risk of treatment-induced heart failure.

March 22, 2017

ASNC, IAC, SNMMI in sync to mandate optimized radiation doses in nuclear cardiology

Organizations are working in sync to put a focus on mandating optimized radiation doses in nuclear cardiology studies performed across the nation and beyond.

November 17, 2016

ASNC, SNMMI release position statement, guidelines on myocardial perfusion PET

After reviewing the available literature, the societies said that rest-stress myocardial perfusion PET was a first-line preferred test for patients with known or suspected coronary artery disease who meet the criteria for stress imaging and are unable to complete the diagnostic level exercise stress imaging study.

August 22, 2016

SCCT honors three young physicians

Three physicians were named finalists for the 10th annual Toshiba Young Investigators Awards, according to an announcement from the Society of Cardiovascular Computed Tomography (SCCT).

June 3, 2016

Goal Reversal? Study Suggests Echocardiography Could Have an Underuse Problem

ASE says new data may be a “wake-up call” to recognize the value of echocardiography.

May 26, 2016

Budoff wins SCCT’s 2016 gold medal award

The Society of Cardiovascular Computed Tomography (SCCT) announced that Matthew J. Budoff, MD, had won its 2016 Gold Medal Award.

April 25, 2016

Using isosmolar contrast agent during angioplasty reduces risk of renal and cardiac events, say data from GE Healthcare supported study

Significantly fewer renal and cardiac events are associated with angioplasty procedures using isosmolar contrast medium (IOCM) agent Visipaque (iodixanol) than those using low-osmolar contrast media (LOCM), demonstrate data from abstracts presented today at the EuroPCR Congress 2015 in Paris.

May 20, 2015

REVA Announces First Clinical Results From ReZolve2 Trial

REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") announced initial clinical results from patients treated with its ReZolve2 sirolimus-eluting bioresorbable coronary scaffold at Transcatheter Therapeutics 2013 ("TCT"), the world's leading interventional cardiology conference, which is being held this week in San Francisco, California. The ReZolve2 trial is currently enrolling up to 125 patients at multiple centers in Australia, Brazil, Europe, and New Zealand to provide the data needed to apply for European CE Marking. Patient enrollment was initiated in March 2013 and is currently ongoing.

October 29, 2013

Around the web

Cardiovascular Business

AI improves CT assessments, boosts care for real-world heart patients

Automated AI-generated measurements combined with annotated CT images can improve treatment planning and help referring physicians and patients better understand their disease, explained Sarah Jane Rinehart, MD, director of cardiac imaging with Charleston Area Medical Center.

Cardiovascular Business

AI predicts cardiovascular risk during CT scans—no invasive tests or contrast required

Two advanced algorithms—one for CAC scores and another for segmenting cardiac chamber volumes—outperformed radiologists when assessing low-dose chest CT scans.

Radiology Business

Google teams with Bayer to address radiologist burnout via AI

"Gen AI can help tackle repetitive tasks and provide insights into massive datasets, saving valuable time," Thomas Kurian, CEO of Google Cloud, said Tuesday.